Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Change in Acquisitions & Divestments (2024 - 2025)

Connect Biopharma Holdings' Change in Acquisitions & Divestments history spans 2 years, with the latest figure at $14.4 million for Q3 2025.

  • For Q3 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $14.4 million; the TTM value through Sep 2025 reached $29.7 million, changed N/A, while the annual FY2024 figure was $12.8 million, 87.64% down from the prior year.
  • Change in Acquisitions & Divestments for Q3 2025 was $14.4 million at Connect Biopharma Holdings, up from $13.3 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $14.4 million in Q3 2025 and bottomed at $2.0 million in Q1 2025.